The authors specifically note the lack of randomized controlled trials for orthopaedic indications—meaning we can’t confidently say it works, what the true aspect-result profile is, or what a “safe dose” might be in the real globe (systematic assessment, 2024). If your aim is “significantly less downtime, more education,” there’s a https://paxtonkewmd.jts-blog.com/37860943/new-step-by-step-map-for-peptide-bpc-157